Tryton Medical Receives FDA Approval for Tryton Side Branch Stent to Treat Significant Coronary Bifurcation Lesions
7 March 2017
Tryton Medical, Inc., the leading developer of stents designed to treat coronary bifurcation lesions, today announced the U.S. Food and Drug Administration (FDA) has ap